Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SL278P is a non-coding RNA gene classified as a pseudogene for the 7SL RNA component of the signal recognition particle. Pseudogenes like RN7SL278P are genomic DNA sequences similar to known genes but are typically non-functional due to mutations, truncations, or lack of regulatory elements. While the functional 7SL RNA (coded by RN7SL1) acts as a scaffold in the signal recognition particle complex for co-translational protein targeting, RN7SL278P does not encode a functional RNA and is not involved in protein synthesis, signaling, or identified disease processes[4][8][9]. There is no evidence it acts as a therapeutic target, biomarker, or displays drug interactions. The nomenclature and biological context indicates this entry is not a true receptor, enzyme, or otherwise functional target[4][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 278, pseudogene (RN7SL278P).